Two research vials of lyophilized peptide powder beside a volumetric flask and pipette, illustrating in vitro stock concentration preparation
Mindful Research

BPC-157, TB-500 Blend: Vial Reconstitution and Stock Concentration Math (In Vitro)

By: Mindful Research Team2 min read

Key takeaways

  • In a 10 mg / 10 mg vial both peptides reach the same mg/mL in a shared volume.
  • Molarity differs: at 2 mL, BPC-157 is ~3.52 mM and TB-500 ~1.01 mM.
  • The 1:1 mass ratio is roughly a 3.5:1 molar ratio favouring BPC-157 (the lighter peptide).
  • Earlier 5 mg / 5 mg lots halve every mass figure at the same volume.
  • For in vitro research use only.

Reconstituting the 10 mg / 10 mg BPC-157, TB-500 vial in a single aqueous volume gives each peptide its own molar concentration—both sit at the same mg/mL, but because TB-500 is ~3.5× heavier than BPC-157 its molarity is correspondingly lower.

This is a concentration-math reference for the BPC-157, TB-500 blend, using a suitable solvent such as reconstitution solution (bacteriostatic water). Figures are in vitro stock concentrations, not quantities for any living system.

What concentration does each component reach?

For a 10 mg / 10 mg vial, both peptides share the reconstitution volume, so both reach the same mass concentration (mg/mL). Converting to molarity uses each peptide’s molecular weight (BPC-157 1419.5 g/mol; TB-500 4963 g/mol):

Solvent added Each at (mg/mL) BPC-157 (mM) TB-500 (mM)
1 mL 10.0 7.05 2.02
2 mL 5.0 3.52 1.01
3 mL 3.33 2.35 0.67

Worked example at 2 mL: 10 mg ÷ 2 mL = 5 mg/mL for each peptide. For BPC-157, 5 mg/mL ÷ 1419.5 g/mol = 3.52 mM. For TB-500, 5 mg/mL ÷ 4963 g/mol = 1.01 mM. The general method is in the concentration and reconstitution math guide.

Why do the two molarities differ at the same mg/mL?

Molarity is moles per litre, and moles depend on molecular weight. At an identical mass concentration, the lighter molecule (BPC-157) contributes more moles than the heavier one (TB-500). So although the label ratio is 1:1 by mass, the molar ratio in solution is roughly 3.5:1 in favour of BPC-157. Researchers normalising by molarity rather than mass should keep this in mind.

How is the reconstituted blend handled?

Standard peptide practice applies: add solvent down the vial wall, let the powder dissolve without vigorous agitation, and aliquot to limit freeze–thaw cycles. Earlier 5 mg / 5 mg lots halve every mass figure above at the same volume. See the single-compound pages for component-specific notes: BPC-157 and TB-500.

Related research guides

Research-use note

All materials discussed are supplied for in vitro laboratory research use only, and are not for human or animal use.

Frequently asked questions

What concentration does a 10/10 mg BPC-157, TB-500 vial reach?

Both peptides reach the same mg/mL in a shared volume; at 2 mL that is 5 mg/mL each, which is about 3.52 mM BPC-157 and 1.01 mM TB-500. Concentration math guide

Why do BPC-157 and TB-500 have different molarities at the same mg/mL?

Molarity depends on molecular weight; the lighter BPC-157 (1419.5 g/mol) contributes more moles than the heavier TB-500 (4963 g/mol) at equal mass concentration. TB-500 profile

How are earlier 5/5 mg lots handled?

Every mass figure halves at the same solvent volume, so concentrations are half those of the 10/10 mg vial. Blend profile